Safilo Financial Statements From 2010 to 2025
| SAFLF Stock | USD 2.20 0.00 0.00% |
Check Safilo Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Safilo Group's main balance sheet or income statement drivers, such as , as well as many indicators such as . Safilo financial statements analysis is a perfect complement when working with Safilo Group Valuation or Volatility modules.
Safilo |
Safilo Group SpA Company Return On Equity Analysis
Safilo Group's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Safilo Group Return On Equity | 0.16 |
Most of Safilo Group's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Safilo Group SpA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Safilo Group SpA has a Return On Equity of 0.1579. This is 100.66% lower than that of the Healthcare sector and 102.64% lower than that of the Medical Instruments & Supplies industry. The return on equity for all United States stocks is 150.94% lower than that of the firm.
Safilo Group SpA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Safilo Group's current stock value. Our valuation model uses many indicators to compare Safilo Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Safilo Group competition to find correlations between indicators driving Safilo Group's intrinsic value. More Info.Safilo Group SpA is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.26 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Safilo Group SpA is roughly 3.83 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Safilo Group's earnings, one of the primary drivers of an investment's value.About Safilo Group Financial Statements
Safilo Group stakeholders use historical fundamental indicators, such as Safilo Group's revenue or net income, to determine how well the company is positioned to perform in the future. Although Safilo Group investors may analyze each financial statement separately, they are all interrelated. For example, changes in Safilo Group's assets and liabilities are reflected in the revenues and expenses on Safilo Group's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Safilo Group SpA. Please read more on our technical analysis and fundamental analysis pages.
Safilo Group S.p.A. engages in the design, production, wholesale, and retail distribution of products for the eyewear market in North America, Europe, the Asia Pacific, and internationally. Safilo Group S.p.A. was founded in 1878 and is headquartered in Padua, Italy. Safilo Group operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 4457 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Safilo Pink Sheet
Safilo Group financial ratios help investors to determine whether Safilo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Safilo with respect to the benefits of owning Safilo Group security.